Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today:
Reaching the 55,000 Canadians affected by a brain tumour is the mission of Brain Tumour Foundation of Canada and critical to this, is awareness about support, information, education and research.
Media across Canada are important partners in this effort as we work together to create meaningful and impactful stories that are important to your audience. We want to work with you to share information about this devastating disease, to promote the important support and information services offered, to talk about advances in research and provide opportunities for Canadians to get involved no matter where they live.
Please browse this section for further information and contact us to learn more.
Manager, Marketing and Public Affairs
1-800-265-5106 ext. 232
New research about the brain tumour treatment Bevacizumab (Avastin®) was released at the recent American Society of Clinical Oncology (ASCO) 2013 Annual Meeting. Results were presented from two recent clinical trials focused on the treatment. Because Avastin is one of the few new treatments that have been offered to brain tumour patients in recent years, Brain Tumour Foundation of Canada was eagerly awaiting these results.Learn more
When Carol Kovosi talks about......Learn more
In 2011 Micah Nepon’s brother Jonah was diagnosed......Learn more